Arintra Receives A+* Partnership Rating in KLAS Emerging Company Spotlight Report
Arintra, a GenAI-native autonomous medical coding platform for health systems and physician groups, today announced the publication of a KLAS Emerging Company Spotlight report based on customer experiences with the Arintra platform. The report validates that customers selected Arintra for its vision and transparency, saw real-world results, and committed for the long term.
The report, Arintra Autonomous Medical Coding 2026, is based on interviews with Arintra customers across large health systems, physician groups, and more.
Arintra received an overall performance score of 93 out of 100, with A and A+ grades across the majority of key performance indicators, including an A+ on partnership and fair and transparent charging, and A grades on solution capabilities and likelihood to recommend. Customers told KLAS they selected Arintra for its detailed product roadmap, vendor honesty, and the ability to grow with the solution, with customers noting that Arintra's functionality was ahead of other vendors they evaluated. 100%* of respondents reported that Arintra is part of their long-term plans and that they would purchase the solution again.
One director interviewed by KLAS spoke to the strength of the partnership: "Arintra's strength is their interactive support or their reaction to support. Their turnaround times are really good, and the quality of the outcomes is very strong. My account manager does an excellent job. They are great to work with, and they really partner with us well."
Know More About Arintra Receives A+* Partnership Rating in KLAS Emerging Company Spotlight Report
Comments
Post a Comment